These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29788456)

  • 21. pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures.
    Velloso JPL; Ascher DB; Pires DEV
    Bioinform Adv; 2021; 1(1):vbab031. PubMed ID: 34901870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting functional effect of human missense mutations using PolyPhen-2.
    Adzhubei I; Jordan DM; Sunyaev SR
    Curr Protoc Hum Genet; 2013 Jan; Chapter 7():Unit7.20. PubMed ID: 23315928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the performance of computational predictors for estimating protein stability changes upon missense mutations.
    Iqbal S; Li F; Akutsu T; Ascher DB; Webb GI; Song J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34058752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Predikin webserver: improved prediction of protein kinase peptide specificity using structural information.
    Saunders NF; Kobe B
    Nucleic Acids Res; 2008 Jul; 36(Web Server issue):W286-90. PubMed ID: 18477637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSM-peptides: A computational approach to rapid identification of therapeutic peptides.
    Rodrigues CHM; Garg A; Keizer D; Pires DEV; Ascher DB
    Protein Sci; 2022 Oct; 31(10):e4442. PubMed ID: 36173168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pdCSM-cancer: Using Graph-Based Signatures to Identify Small Molecules with Anticancer Properties.
    Al-Jarf R; de Sá AGC; Pires DEV; Ascher DB
    J Chem Inf Model; 2021 Jul; 61(7):3314-3322. PubMed ID: 34213323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of computational methods for predicting the effects of missense mutations in human cancers.
    Gnad F; Baucom A; Mukhyala K; Manning G; Zhang Z
    BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S7. PubMed ID: 23819521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mmCSM-AB: guiding rational antibody engineering through multiple point mutations.
    Myung Y; Pires DEV; Ascher DB
    Nucleic Acids Res; 2020 Jul; 48(W1):W125-W131. PubMed ID: 32432715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSM-AB: graph-based antibody-antigen binding affinity prediction and docking scoring function.
    Myung Y; Pires DEV; Ascher DB
    Bioinformatics; 2022 Jan; 38(4):1141-1143. PubMed ID: 34734992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ELASPIC2 (EL2): Combining Contextualized Language Models and Graph Neural Networks to Predict Effects of Mutations.
    Strokach A; Lu TY; Kim PM
    J Mol Biol; 2021 May; 433(11):166810. PubMed ID: 33450251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DescFold: a web server for protein fold recognition.
    Yan RX; Si JN; Wang C; Zhang Z
    BMC Bioinformatics; 2009 Dec; 10():416. PubMed ID: 20003426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HGDiscovery: An online tool providing functional and phenotypic information on novel variants of homogentisate 1,2- dioxigenase.
    Karmakar M; Cicaloni V; Rodrigues CHM; Spiga O; Santucci A; Ascher DB
    Curr Res Struct Biol; 2022; 4():271-277. PubMed ID: 36118553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites.
    Huang HD; Lee TY; Tzeng SW; Horng JT
    Nucleic Acids Res; 2005 Jul; 33(Web Server issue):W226-9. PubMed ID: 15980458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. K-Map: connecting kinases with therapeutics for drug repurposing and development.
    Kim J; Yoo M; Kang J; Tan AC
    Hum Genomics; 2013 Sep; 7(1):20. PubMed ID: 24060470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-guided machine learning prediction of drug resistance mutations in Abelson 1 kinase.
    Zhou Y; Portelli S; Pat M; Rodrigues CHM; Nguyen TB; Pires DEV; Ascher DB
    Comput Struct Biotechnol J; 2021; 19():5381-5391. PubMed ID: 34667533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. piscesCSM: prediction of anticancer synergistic drug combinations.
    AlJarf R; Rodrigues CHM; Myung Y; Pires DEV; Ascher DB
    J Cheminform; 2024 Jul; 16(1):81. PubMed ID: 39030592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kin-Driver: a database of driver mutations in protein kinases.
    Simonetti FL; Tornador C; Nabau-Moretó N; Molina-Vila MA; Marino-Buslje C
    Database (Oxford); 2014; 2014():bau104. PubMed ID: 25414382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence and structure signatures of cancer mutation hotspots in protein kinases.
    Dixit A; Yi L; Gowthaman R; Torkamani A; Schork NJ; Verkhivker GM
    PLoS One; 2009 Oct; 4(10):e7485. PubMed ID: 19834613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the functional consequences of somatic missense mutations found in tumors.
    Carter H; Karchin R
    Methods Mol Biol; 2014; 1101():135-59. PubMed ID: 24233781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DDMut: predicting effects of mutations on protein stability using deep learning.
    Zhou Y; Pan Q; Pires DEV; Rodrigues CHM; Ascher DB
    Nucleic Acids Res; 2023 Jul; 51(W1):W122-W128. PubMed ID: 37283042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.